- Home
- AIO vs AGL Comparison
AIO vs AGL Comparison
Compare AIO & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.02
Company Overview
Basic Information| Metric | AIO | AGL |
|---|---|---|
| Founded | 2019 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Managed Health Care |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 805.3M | 422.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIO | AGL |
|---|---|---|
| Price | $22.93 | $1.02 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $2.77 |
| AVG Volume (30 Days) | 141.5K | ★ 5.8M |
| Earning Date | 01-01-0001 | 02-24-2026 |
| Dividend Yield | ★ 9.05% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,885,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.21 |
| 52 Week Low | $15.09 | $0.51 |
| 52 Week High | $20.25 | $6.08 |
Technical Indicators
Market Signals| Indicator | AIO | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 71.00 |
| Support Level | $23.03 | $0.91 |
| Resistance Level | $23.57 | $0.82 |
| Average True Range (ATR) | 0.42 | 0.07 |
| MACD | 0.11 | 0.03 |
| Stochastic Oscillator | 63.73 | 91.31 |
Price Performance
Historical Comparison AIO
AGL
About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.